RESEARCH LIBRARY: 100+ studies · FDA data · Poison center reports · Policy analysis → GlobalKratom.org
RESEARCH LIBRARY: 100+ studies · FDA data · Poison center reports · Policy analysis → GlobalKratom.org
@AntiKratom Join the fight — follow for alerts, evidence & action calls
Pennsylvania HB 2657 kratom regulation and enforcement analysis
Pennsylvania · HB 2657

A KCPA Fail in the Making?

HB 2657 draws chemical lines around kratom. The harder question is who will inspect the shelves, test the products and prove which side of those lines a package actually falls on.

Rep. Bridget Kosierowski’s HB 2657 has real penalties. What it does not spell out is a statewide shelf-inspection and laboratory-testing system capable of continuously verifying the chemistry of kratom sold across Pennsylvania.

The 30-second version

It keeps kratom legal. “Natural” leaf and raw leaf powder may remain on retail shelves.

It bans defined “synthetic” products. That includes products over 10 ppm mitragynine pseudoindoxyl (MP), over the bill’s 7-OH threshold, synthetic alkaloids, and products outside its narrow natural-product definition.

It has penalties. Criminal penalties apply to knowing or intentional violations of the synthetic-product prohibition; Section 4 violations can bring civil penalties.

But enforcement still requires evidence. A package saying “natural” does not tell an inspector its MP concentration—or whether an alkaloid was synthetically produced.

1. First Problem: The Label Is Not the Chemistry

HB 2657 requires a retail product to carry a verification that it is in “natural form.” But the bill does not require every retail lot to arrive with an independent certificate of analysis establishing compliance with its chemical thresholds.

OPMS Silver Green Vein Maeng Da kratom package
Look at the package. OPMS Silver says “organic” and “all natural.” Mitragynine pseudoindoxyl is not disclosed on the pictured front label. A March 2025 Anresco laboratory report on an OPMS Silver Green Vein Maeng Da sample measured MP at 1.34 mg/g—about 1,340 ppm. HB 2657 draws its line at 10 ppm. The report concerns the tested sample and does not establish the composition of every OPMS Silver lot.
The package can say “all natural.” The statute can say 10 ppm. Neither tells an inspector what is actually inside the capsule.

2. Who Is Going Store to Store?

The bill requires processors and retailers to register with the Department of Health and caps each registration or renewal fee at $100. Those fees are directed to enforcement.

But the introduced bill does not establish a dedicated kratom inspection unit, a mandatory inspection frequency, random shelf sampling, lot-by-lot testing, or a specific laboratory surveillance program.

So the practical question for lawmakers is simple: who is going into Pennsylvania’s vape shops, smoke shops and other kratom retailers, pulling products from shelves and checking whether the chemistry matches the label?

Registration tells Pennsylvania who says they are selling kratom. It does not, by itself, tell Pennsylvania what is inside the products they sell.

3. Yes, There Is an Enforcement Mechanism. But Read What It Actually Does.

HB 2657 is not identical to South Carolina’s problem. Pennsylvania’s bill expressly provides enforcement authority for Section 4: the Attorney General, state or local law enforcement, and local government units may investigate suspected Section 4 violations. It also provides civil penalties and consumer remedies.

For Section 3, knowingly or intentionally manufacturing, delivering, selling, or possessing with intent to sell a prohibited synthetic kratom product is a misdemeanor carrying up to a $15,000 fine, five years' imprisonment, or both.

But statutory authority is only half the problem. To enforce a chemistry-based prohibition, somebody still has to obtain the product, analyze it, interpret the result and establish the violation.

South Carolina exposed the danger of writing consumer protection before resolving how it works in the real world. Pennsylvania gives agencies more explicit enforcement language—but HB 2657 still leaves major operational questions unanswered in the introduced text.
Bathroom stalls with unusually short privacy doors
Protection on paper is not the same thing as protection in practice. HB 2657 supplies legal boundaries and penalties. The question is whether Pennsylvania will build the inspection, sampling and laboratory system needed to enforce them consistently.

4. And What Test Proves “Natural” Versus “Synthetic”?

This is the question the bill should force into the open.

A quantitative laboratory assay can measure how much MP or 7-OH is present. That can answer whether a tested sample crosses a numerical concentration threshold.

But concentration is not the same question as origin. If Pennsylvania wants enforcement to depend on whether an alkaloid is naturally occurring, extracted, concentrated, converted or synthetically derived, lawmakers should identify what validated analytical method will establish that distinction—and what evidentiary standard regulators and courts are supposed to use.

Questions HB 2657 should answer before Pennsylvania relies on it

Who inspects? Which agency personnel conduct routine retail inspections?

How often? Is inspection complaint-driven, random, annual—or something else?

Who samples? Who has responsibility for pulling suspect products and maintaining chain of custody?

Who tests? Which state or contracted laboratory performs quantitative alkaloid analysis?

What method? What validated test distinguishes a naturally occurring constituent from one that was synthetically derived or chemically converted?

Who pays? A registration fee cannot substitute for an actual statewide testing plan.

What happens while testing is pending? Can suspect inventory be held or removed before the laboratory result returns?

5. Meanwhile, Federal Law Has Already Moved

DEA placed mitragynine pseudoindoxyl, MGM-15 and MGM-16 in federal Schedule I effective August 26, 2026. HB 2657 nevertheless uses a state definition under which a product becomes “synthetic” based in part on exceeding 10 ppm MP.

That makes accurate identification more—not less—important. Pennsylvania would be regulating products in a market where the relevant chemistry can carry consequences under both state and federal law.

The Question for Rep. Kosierowski

HB 2657 can print “natural,” “synthetic,” “10 ppm” and “0.5%” into Pennsylvania law. The shelf does not read the statute.

Who inspects the retailers? Who takes the samples? Who runs the tests? What test establishes synthetic origin? And what happens when the package says “all natural” but the laboratory says something else?

A chemical limit without a practical system for finding violations risks becoming a very precise number on a piece of paper.